mRNA-1083 vaccine
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for mRNA-1083 vaccine, covering 2025-10-20 to 2025-12-02. Get the full timeline:
Most recent: Clinical Trial Update: Study to Investigate the Immunogenicity, Reactogenicity, and Safety of mRNA-1083 Vaccine (SARS-CoV-2 [COVID-19] and Influenza) in Adults ≥50 Years of Age [Phase 3]